BIO Events
Patient advocacy drives innovation: James Roe’s asthma story comes to BIO 2026
When BIO President & CEO John F. Crowley met INDY NXT racer James Roe at a Notre Dame game, something clicked. It wasn’t a shared ...
Read More
Latest News
LATEST STORIES
Latest News
BIO supports and seeks refinements to FDA’s Plausible Mechanism Framework
Advances in individualized therapies targeting specific genetic conditions offer the promise of new treatments for rare diseases, but with so few patients, it can be ...
BIO's View
Exaggerated MFN cost-saving estimates imperil U.S. innovation and investment
The Administration’s Council of Economic Advisors (CEA) has released an analysis of savings expected from its “Most Favored Nation” deals with pharmaceutical manufacturers, but the ...
Health
Parkinson’s disease in women: Research gaps, treatment challenges, and new hope through GEM-PD
May is Women’s Health Month and in observation, Bio.News sat down with Ragasudha Botta, MBBS, PhD, MMSc, Senior Scientific Director, Critical Path for Parkinson’s (CPP) ...
WHAT YOU MISSED AT THE LATEST BIO EVENTS
Patient advocacy drives innovation: James Roe’s asthma story comes to BIO 2026
When BIO President & CEO John F. Crowley met INDY NXT racer James Roe at a Notre Dame game, something clicked. It wasn’t a shared ...
Read More
State of play: BIO Coffee Chat covers how state policies impact access
“We’re finding that the most disruptive pieces of legislation are much more likely to advance in state legislatures first, before eventually gaining traction at the ...
Read More